SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

AEON Biopharma Q3 net income rises, biosimilarity program advances

AEON Biopharma Q3 net income rises, biosimilarity program advances Overview US biopharmaceutical fir

AEON

Related stories